Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:24:49 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BIOV - C  45.00.065H0.0758.00.07    0.10  0.01May 1507:4115 min RT 2¢
CSE - C45.00.065H0.0758.00.07    0.10  0.01May 1515 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-16 07:41C:BIOV0.07News ReleaseCanadian Investment Regulatory Organization Trading Halt - BIOV
2024-05-16 07:37C:BIOV0.07Halt TradingBiovaxys Technology halted at the open
2024-05-10 18:19C:BIOV0.08News ReleaseBiovaxys closes $279,625 second tranche of financing
2024-05-03 18:43C:BIOV0.08News ReleaseBiovaxys closes $333,227 first tranche of placement
2024-04-30 13:35C:BIOV0.075News ReleaseBiovaxys Technology appoints Cherry as CFO
2024-03-22 17:21C:BIOV0.085News ReleaseBiovaxys arranges $1-million private placement
2024-03-07 16:39C:BIOV0.07News ReleaseBiovaxys Technology has no material changes
2024-03-06 16:55C:BIOV0.085News ReleaseBiovaxys receives voluntary mgmt cease trade order
2024-03-05 12:12C:BIOV0.09News ReleaseBiovaxys receives DPX patent notice of allowance
2024-02-21 14:37C:BIOV0.09News ReleaseBiovaxys Technology competes IMV asset acquisition
2024-02-12 14:45C:BIOV0.09News ReleaseBiovaxys Technology acquires DPX tech asset porfolio
2024-02-12 14:35C:BIOV0.065Resume TradingBiovaxys Technology to resume at 12 p.m. PT
2024-02-12 11:40C:BIOV0.065Halt TradingBiovaxys Technology halted at 8:37 a.m. PT
2024-01-29 10:13C:BIOV0.05News ReleaseBiovaxys settles $215,000 debt with shares
2023-12-22 13:07C:BIOV0.02News ReleaseBiovaxys signs LOI to acquire immunotherapeutics tech
2023-12-21 23:54C:BIOV0.02News ReleaseBiovaxys, Procare cancel U.S. distribution agreement
2023-12-13 11:44C:BIOV0.015News ReleaseBiovaxys in talks to acquire immunotherapeutics assets
2023-11-24 16:34C:BIOV0.02Cease Trade Company RescindedBiovaxys Technology reinstated for trading
2023-11-24 13:05C:BIOV0.025Resume TradingBiovaxys Technology to resume at 10:30 a.m. PT
2023-11-14 17:44C:BIOV0.025SEDAR Interim MD & ASEDAR Interim MD & A